Emergent BioSolutions Inc (EBS)

8.27 -0.15 (-1.78%) USD  |  NYSE  |  Dec 27, 16:00
8.27 0.00 (0.00%) After-Hours: 20:00
More

Emergent BioSolutions Research and Development Expense (Quarterly): 13.80M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 713.00M
Tonix Pharmaceuticals Holding Corp 9.114M
Chimerix Inc 19.65M
Geron Corp 20.15M
MAIA Biotechnology Inc 2.667M